Buy or sell Symbiont stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Symbiont Stock
Symbiont has developed the market-leading platform for institutional applications of blockchain technology.
About Symbiont Stock
Symbiont has developed the market-leading platform for institutional applications of blockchain technology. Symbiont smart contracts enable complex instruments to live their entire lifecycle on a truly decentralized, enterprise blockchain network with end-to-end privacy. Financial institutions and governments are working with Symbiont to develop new business lines, increase transparency, reduce risk, and save costs. Industry leaders such as Vanguard and the State of Delaware have chosen to partner with Symbiont. Headquartered in New York City, Symbiont is a financial technology company founded by a team of experts in capital markets and blockchain technology.
Investors
Wicklow Capital
Blockchain.com, Tipalti, Quanergy Systems, Symbiont, Civil Maps
Funding History
June 2014 | $375K |
---|---|
May 2017 | $15.0M |
Management
Founder
Evan Wagner
Founder & CEO
Mark Smith
Founder & Chief Technology Officer
Adam Krellenstein
Chairman & President
Caitlin Long
Press
CoinDesk - Apr, 9 2018
CoinDesk - Dec, 13 2017
CoinDesk - Jul, 19 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase